- Home
- SDOT vs BIAF Comparison
SDOT vs BIAF Comparison
Compare SDOT & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SDOT | BIAF |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9M | 5.8M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | SDOT | BIAF |
|---|---|---|
| Price | $2.82 | $1.01 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 389.1K | 129.6K |
| Earning Date | 03-10-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $467,078,000.00 | $6,776,739.00 |
| Revenue This Year | $12.76 | N/A |
| Revenue Next Year | $5.54 | $20.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.17 | $0.69 |
| 52 Week High | $35.60 | $46.53 |
Technical Indicators
Market Signals| Indicator | SDOT | BIAF |
|---|---|---|
| Relative Strength Index (RSI) | 47.71 | 42.45 |
| Support Level | $2.68 | $0.69 |
| Resistance Level | $3.01 | $1.31 |
| Average True Range (ATR) | 0.25 | 0.14 |
| MACD | -0.06 | -0.03 |
| Stochastic Oscillator | 16.96 | 42.59 |
Price Performance
Historical ComparisonAbout SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.